SAN JOSE, Calif.--(BUSINESS WIRE)--HemoSense, Inc. (AMEX:HEM) today announced that it has signed an agreement with ManthaMed, a Canadian provider of health screening, monitoring and diagnostic testing technologies, to market and distribute HemoSense’s portable INRatio® PT/INR monitoring system for patient self-testing and healthcare professionals in Canada. The agreement with ManthaMed represents the Company’s 16th international distribution agreement and expands HemoSense’s international distribution reach to 23 countries.
